Thursday, September 3, 2026 | UTC
About | Contact | API Status
Sign In Subscribe
Live
AAPL $324.96 -0.05%
MSFT $496.82 -0.84%
GOOGL $337.12 +0.63%
AMZN $254.98 +0.02%
TSLA $357.01 +0.26%
META $592.85 +2.47%
NVDA $224.41 +3.21%
JPM $356.22 +0.36%
BTC $34.20 +0.09%
ETH $22.84 -1.04%
Latest Signing ceremony for contribution agreements between WHO and France Oct 17, 2024
AAPL
$324.96
▼ 0.05%
MSFT
$496.82
▼ 0.84%
GOOGL
$337.12
▲ 0.63%
AMZN
$254.98
▲ 0.02%
TSLA
$357.01
▲ 0.26%
META
$592.85
▲ 2.47%
NVDA
$224.41
▲ 3.21%
JPM
$356.22
▲ 0.36%

Top Stories

Markets →
The Guardian Health
Thousands of people begin receiving their first deliveries of once-a-day medication made by Novo NordiskBusiness live – latest updatesA once-a-day Wegovy weight-loss pill has gone on sale at high street and online pharmacies in the UK, but is not yet available on the NHS.Thousands of people began receiving their first deliveries of the pill, made by the Danish drugmaker Novo Nordisk, on Monday. It contains the same active GLP-1 ingredient as the Wegovy jab, semaglutide, and is similarly effectiv
health  Jul 6, 2026
Bloomberg Markets
Anneka Treon, ING Global Head of Private Banking, Wealth Management & Investments, joins Bloomberg’s Vonnie Quinn on “Bloomberg Brief” to discuss how investors are navigating through various supply shocks. (Source: Bloomberg)
business  Jul 6, 2026

Stay ahead of the markets.

Get free access to breaking news, stock data, and market analysis.

Subscribe Free